Case: A case of Leydig cell tumor, associated with azoospermia, is presented.
| INTRODUCTION
Testicular tumors represent 1%-1.5% of all tumors in men. Leydig cell tumors are rare, constituting 1% of testicular tumors. In male adolescents, these hormone-secreting interstitial tumors usually are associated with precocious puberty; the clinical features and hormonal levels of these tumors are varied in adults. Most Leydig cell tumors are benign; however, a radical orchiectomy is currently used as the standard therapy for these tumors. This article presents a case of a Leydig cell tumor that was associated with azoospermia that required hormone replacement therapy after surgery. Moreover, this hormone therapy was successful in establishing spermatogenesis in this patient.
| CASE REPORT
A 31 year old male patient was referred to Kyoritsu General Hospital, Nagoya, Japan, owing to azoospermia. Although he had not undergone medical or surgical treatment, he had sustained a scrotal injury from a baseball ball 15 years ago. Azoospermia was confirmed by two semen analyses at the hospital. He was 160 cm tall and weighed 58 kg. His right scrotal content obviously was enlarged and stonyhard in consistency. This enlargement had continued since his scrotal trauma. His left testicle was atrophic (8 mL in volume). His pubic hair was Tanner stage 5 and gynecomastia was absent. The levels of sex hormones, including luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone, free testosterone, and estradiol, were <0.1 mIU/mL, <0.1 mIU/mL, 9.65 ng/mL, 39.5 pg/mL, and 24.8 pg/ mL, respectively. The tumor markers of testicular cancer, including alpha-fetoprotein, beta-human chorionic gonadotropin (beta-hCG), and lactate dehydrogenase, were not elevated. The adrenal hormonal levels were almost normal (Table 1) One month after surgery, the patient was unable to ejaculate and presented with erectile dysfunction and a decreased libido. An endocrine panel revealed significantly decreased levels of testosterone and the low LH level had remained (Table 2) .
Two months after surgery, the patient was put on self- F I G U R E 1 Computed tomography scan showed significant calcification in the right scrotal content, with no adrenal gland tumor or retroperitoneal and pelvic lymph node swelling T A B L E 3 Semen analyses after hormone replacement therapy Recently, an article reported a case of unilateral orchiectomy with synchronous TESE in a patient with elevated delta 4 androstenedione and suppressed LH and FSH. 4 Fortunately, the couple achieved a natural pregnancy because of spermatogenesis recovery after surgery. As surgical resection is considered to result in the normalization of gonadotropins and a decrease in delta 4 androstenedione levels, it was hypothesized that this might have induced the spermatogenesis.
Despite the favorable outcome of one patient 4 years after his orchietomy, elevated estradiol and retroperitoneal lymph node swellings were observed. 5 Another study also reported a patient who presented with a hormone-secreting interstitial tumor of the testis and who developed metastasis 7 years after the removal of a benign primary tumor. 6 Therefore, the need for prudential follow-up by CT scans and serum endocrinological assessments was emphasized. In conclusion, Leydig cell tumors are rare and show variable endocrinological findings, depending on their ability to secrete steroid hormones. In the present case, the Leydig cell tumor was associated with azoospermia. Although the patient's sexual function deteriorated after surgery, hormone replacement therapy with combined LH and FSH successfully recovered and preserved spermatogenesis. Regular check-ups with a CT scan is a mandatory requirement in order to detect the possibility of malignancy with recurrence and metastasis.
